SHERMAN JEFFREY W
SEC Form 4 insider trading activity
SHERMAN JEFFREY W has filed 2 SEC Form 4 filings (27 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Mar 2, 2026.
On the most recent filing, SHERMAN JEFFREY W is listed as Director at Larimar Therapeutics, Inc. Inside the rolling window, SHERMAN JEFFREY W reported 1 open-market purchase totaling $25K in LRMR and no open-market sales.
Companies traded
Other insiders at LRMR
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Aug 28, 2025 | XERS | Sale | $335K |
Frequently asked questions
How many SEC Form 4 filings has SHERMAN JEFFREY W made?
SHERMAN JEFFREY W has filed 2 SEC Form 4 filings (27 transaction rows) across 1 company since 2025.
Which companies does SHERMAN JEFFREY W trade?
SHERMAN JEFFREY W has filed SEC Form 4 disclosures for 1 company, including LRMR.
When was SHERMAN JEFFREY W's most recent SEC Form 4 filing?
SHERMAN JEFFREY W's most recent SEC Form 4 filing on Tracefour is dated Mar 2, 2026.
What is SHERMAN JEFFREY W's total buy and sell value in the current window?
Inside the rolling retention window, SHERMAN JEFFREY W bought $25K and sold $0 based on SEC Form 4 filings.
What was SHERMAN JEFFREY W's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,000 LRMR shares on 2026-02-27, worth $25K, per SEC Form 4 filings.